These data demonstrate that systemic bi-shRNAmousePDX-1 lipoplexes effectively prevent hypoglycemic death in an insulinoma SCID mouse model and result in in situ knockdown of PDX-1 within the islets, leading to suppression of insulin expression and secretion and subsequent hyperglycemia. The gene discussed is INS; the disease is pancreatic insulinoma.